Coherus Oncology, Inc.
Ticker: 1512762
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 14.31+16.2% | 12.31+6.4% | 11.57+12.9% | 10.25+34.9% | 7.60-89.3% | 70.77+8.9% | 64.98-15.7% | 77.06 |
| Total Income | 14.31+16.2% | 12.31+6.4% | 11.57+12.9% | 10.25+34.9% | 7.60-89.3% | 70.77+8.9% | 64.98-15.7% | 77.06 |
| EXPENSES | ||||||||
| Expenditure | 46.64-3.8% | 48.46-13.3% | 55.90+0.3% | 55.74+5.1% | 53.03-31.3% | 77.16-9.7% | 85.49-28.5% | 119.59 |
| PROFIT | ||||||||
| PBT | -33.35+9.7% | -36.94+17.0% | -44.52+0.8% | -44.86+5.4% | -47.40-340.9% | -10.75+16.8% | -12.92-112.6% | 102.88 |
| Net Profit | -20.63+46.2% | -38.33-7.9% | -35.53-111.9% | 297.77+626.4% | -56.57-426.2% | -10.75+16.8% | -12.92-112.6% | 102.88 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00%-90.97pp | -9.03%+22.54pp | -31.56%+23.62pp | -55.18% |
| NPM % | -100.00% | -100.00% | -100.00%-200.00pp | 100.00%+200.00pp | -100.00%-84.81pp | -15.19%+4.69pp | -19.89%-119.88pp | 100.00% |
| EPS | -0.13+53.6% | -0.28+9.7% | -0.31-112.1% | 2.57+624.5% | -0.49-444.4% | -0.09+18.2% | -0.11-112.1% | 0.91 |
Corporate Events
Board MeetingCHRS
202627May
Board Meeting
Coherus Oncology, Inc. held its 2026 Annual Meeting of Stock…
SEC Filing ↗